TP53 and cancer: Thus, tumorigenic cells modify essential metabolic pathways (glycolysis, pentose phosphate pathway and glutaminolysis) and alter cancer-related gene expression (myelocytomatosis oncogene, p53 and pyruvate kinase M2) [34].